Impact of polysomy 17 on HER2 testing of invasive breast cancer patients

Background: Current American Society of Clinical Oncology/College of American Pathologists guidelines define HER2-positive tumors as those with > 6 HER2 genes per nucleus or those with HER2/CEP17 (chromosome 17) ratio > 2.2. These guidelines are potentially contradictory in tumors with polysom...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Liu, Yang, Ma, Li, Liu, Dequan, Yang, Zhibing, Yang, Chengang, Hu, Zaoxiu, Chen, Wenlin, Yang, Zhuangqing, Chen, Sijun, Zhang, Zhuoni
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: e-Century Publishing Corporation 2013
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3885470/
https://ncbi.nlm.nih.gov/pubmed/24427336
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia